Arrowhead Pharmaceuticals, Inc.

JPMORGAN CHASE & CO ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

611,910

Value ($000)

40,625

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	40,625	0.0%	611,910	12/31/2025
2025 Q3	11/7/2025	26,754	0.0%	775,717	9/30/2025
2025 Q2	8/12/2025	6,441	0.0%	407,644	6/30/2025
2025 Q1	5/12/2025	6,213	0.0%	487,671	3/31/2025
2024 Q4	2/12/2025	37,984	0.0%	2,020,426	12/31/2024
2024 Q3	11/8/2024	41,615	0.0%	2,148,405	9/30/2024
2024 Q2	8/12/2024	60,185	0.0%	2,315,705	6/30/2024
2024 Q1	5/10/2024	75,449	0.0%	2,638,063	3/31/2024
2023 Q4	2/12/2024	84,182	0.0%	2,751,048	12/31/2023
2023 Q3	11/14/2023	74,782	0.0%	2,783,098	9/30/2023
2023 Q2	8/11/2023	102,733	0.0%	2,880,914	6/30/2023
2023 Q1	5/18/2023	73,913	0.0%	2,909,965	3/31/2023
2022 Q4	2/13/2023	114,413	0.0%	2,820,822	12/31/2022
2022 Q3	11/14/2022	95,599	0.0%	2,892,521	9/30/2022
2022 Q2	8/11/2022	105,306	0.0%	2,990,815	6/30/2022
2022 Q1	5/11/2022	134,334	0.0%	2,920,953	3/31/2022
2021 Q4	2/11/2022	197,511	0.0%	2,979,064	12/31/2021
2021 Q3	11/12/2021	177,253	0.0%	2,839,242	9/30/2021
2021 Q2	8/12/2021	219,145	0.0%	2,646,045	6/30/2021
2021 Q1	5/12/2021	170,611	0.0%	2,572,922	3/31/2021
2020 Q4	2/19/2021	184,891	0.0%	2,409,631	12/31/2020
2020 Q3	11/12/2020	63,680	0.0%	1,466,619	9/30/2020
2020 Q2	8/11/2020	18,153	0.0%	420,304	6/30/2020
2020 Q1	5/12/2020	11,909	0.0%	413,937	3/31/2020
2019 Q4	2/11/2020	36,323	0.0%	572,640	12/31/2019